A comparative analysis of standard and alternative antidepressants in the treatment of human immunodeficiency virus patients

Comprehensive Psychiatry

Volumn 37, Issue 6, 1996, Pages 402-408

  Wagner, Glenn J ^a   Rabkin, Judith G ^b   Rabkin, Richard ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DEXAMPHETAMINE; FLUOXETINE; IMIPRAMINE; SERTRALINE; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG CHOICE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0029830795     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-440X(96)90023-1     Document Type: Article

References (34)

1. Brown GR, Rundell JR. Prospective study of psychiatric morbidity in HIV-seropositive women without AIDS. Gen Hosp Psychiatry 1990;12:1-6.
2. Perkins DO, Stern RA, Golden RN, Murphy C, Naftolowitz D, Evans DL. Mood disorders in HIV infection: prevalence and risk factors in a nonepicenter of the AIDS epidemic. Am J Psychiatry 1994;151:233-236.
3. Perry SW, Jacobsberg L, Card C, Ashman T, Frances A, Fishman B. Severity of psychiatric symptoms after HIV testing. Am J Psychiatry 1993;150:775-779.
4. Rabkin JG, Remien RH, Katoff L, Williams JBW. Resilience in adversity among longterm survivors with AIDS. Hosp Community Psychiatry 1993;44:162-167.
5. Rosenberger PH, Bornstein RA, Nasrallah HA, Para MF, Whitaker CC, Fass RJ, et al. Psychopathology in HIV Infection: lifetime and current assessment. Compr Psychiatry 1993;34:150-158.
6. Williams JBW, Rabkin JG, Remien RH, Gorman JM, Ehrhardt AA. Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. II. Standardized clinical assessment of current and lifetime psychopathology. Arch Gen Psychiatry 1991;48:124-130.
7. Lipsitz JD, Williams JBW, Rabkin JG, Remien RH, Bradbury M, el-Sadr W, et al. Psychopathology in male and female intravenous drug users with and without HIV infection. Am J Psychiatry 1994;151:1662-1668.
8. Manning D, Jacobsberg L, Erhart S, Perry S, Frances A. The efficacy of imipramine in the treatment of HIV-related depression. International Conference on AIDS 1990;6 (abstr ThB32).
9. Rabkin JG, Rabkin R, Harrison W, Wagner G. Effects of imipramine on mood and immune status in depressed patients with HIV illness. Am J Psychiatry 1994;151:516-523.
10. Levine S, Anderson D, Bystritsky A, Baron D. A report of eight HIV-seropositive patients with major depression responding to fluoxetine. J AIDS 1990;3:1074-1077.
11. Rabkin JG, Rabkin R, Wagner G. Fluoxetine effects on mood and immune status in depressed patients with HIV illness. J Clin Psychiatry 1994;55:92-97.
12. Rabkin JG, Wagner G, Rabkin R. Sertraline effects on mood and immune status in patients with major depres-sion and HIV illness: an open trial. J Clin Psychiatry 1994;55:433-439.
13. Fernandez F, Adams F, Holmes VF, Levy JK, Neidhart M. Methylphenidate for depressive disorders in cancer patients. Psychosomatics 1987;28:455-462.
14. Kaufmann MW, Murray GB. The use of d-amphetamine in medically ill depressed patients. J Clin Psychiatry 1982;43:463-464.
15. Masand PS, Pickett P, Murray GB. Psychostimulants for secondary depression in medical illness. Psychosomatics 1991;32:203-208.
16. Wallace AE, Kofoed LL, West AN. Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients. Am J Psychiatry 1995;152:929-931.
17. Woods SW, Tesar GE, Murray GB, Cassem NH. Psychostimulant treatment of depressive disorders secondary to medical illness. J Clin Psychiatry 1986;47:12-15.
18. Rabkin JG. Psychostimulant medication for depression and lethargy in HIV illness: a pilot study. Am Soc Clin Psychopharmacol Prog Notes 1994;4:1.
19. Angrist B, D'Hollosy M, Sanfilipo M, Satriano J, Diamond G, Simberkoff M, et al. Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment. J Clin Psychopharmacol 1992; 12:268-272.
20. Fernandez F, Levy JL, Galizzi H. Response of HIV-related depression to psychostimulants: case reports. Hosp Community Psychiatry 1988;39:628-631.
21. Holmes VF, Fernandez F, Levy JK. Psychostimulant response in AIDS-related complex patients. J Clin Psychiatry 1989;50:5-8.
22. Nelson JC. Psychostimulants in the treatment of depression. Prim Psychiatry 1995;2:26-27.
23. Satel SL, Nelson JC. Stimulants in the treatment of depression: a critical overview. J Clin Psychiatry 1989;50:241-249.
24. Rubin RT. Sex steroid hormone dynamics in endogenous depression: a review. Int J Ment Health 1981;10: 43-59.
25. Vogel W, Klaiber E, Broverman D. A comparison of the antidepressant effects of a synthetic androgen (Mesterolone) and amitriptyline in depressed men. J Clin Psychiatry 1985;46:6-8.
26. Luisi M, Franchi F. Double-blind group comparative study of testosterone undecanoate and mesterolone in hypogonadal male patients. J Endocrinol Invest 1980;3:305-308.
27. O'Carroll R, Bancroft J. Testosterone therapy for low sexual interest and erectile dysfunction in men: a controlled study. Br J Psychiatry 1984;145:145-151.
28. O'Carroll R, Shapiro C, Bancroft J. Androgens, behavior and nocturnal erection in hypogonadal men: the effects of varying the replacement dose. Clin Endocrinol 1985;23:527-538.
29. Salmimies P, Kockett G, Pirk KM. Effects of testosterone replacement on sexual behavior in hypogonadal men. Arch Sex Behav 1981;22:345-353.
30. Rabkin JG, Rabkin R, Wagner G. Testosterone replacement therapy in HIV illness. Gen Hosp Psychiatry 1995;17:37-42.
31. Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-III-R (SCID). New York, NY: Biometrics Research Division, New York State Psychiatric Institute, 1986.
32. Williams JBW. The Structured Interview Guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 1988;45:742-747.
33. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296.
34. Munoz A, Carey V, Saah AJ, Phair JP, Kingsley LA, Fahey JL, et al. Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus. J AIDS 1988;1:396-404.